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Topic 05 – Arrhythmias and stimulation
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gada syndrome is independantly related to symptoms or arrhythm
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Introduction: Risk stratification in Brugada syndrome (BS) remains
largely debated and relies to date mainly on spontaneous ECG type 1 and
symptoms. Transmural dispersion of repolarisation is a promising parameter
which has been linked to arrhythmic events in BS in a few recent works
including a limited number of patients.
Methods: ECGs from 238 BS patients were reviewed (45±12 years old,
188 males). Baseline ECG (n=126) or ECG after provocative test (n=112)
with the highest ST elevation were selected in each patient. Tpe was measured
in each 12 ECG leads. 99 patients were implanted with an ICD. 72 patients
(30%) presented an arrhythmic event defined by unexplained syncope (54 pts),
SD (8 pts) or ICD appropriated therapies (14 pts).
Results: Tpe in V1 to V4, Tpe maximum value and Tpe dispersion in pre-
cordial leads were significantly higher in symptomatic versus asymptomatic
patients (table). Tpe in peripheral leads does not add some further information.
In multivariate analysis, a Tpe>90 ms in precordial leads was an indepen-
dently related to any arrhythmic event (OR 7.29, [2.99-17.8], p<0.001), with
a sensitivity and specificity of 72% and 80% respectively.
Conclusion: Marker of transmural dispersion of repolarization such as Tpe
in precordial leads is highly related to symptoms and mortality in BS. This
simple ECG parameter could be used for further risk stratification.
Table – Tpe values according to clinical presentation
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Introduction: Monomorphic sustained ventricular tachycardia (MSVT) in
structural heart disease (SHD) carry poor prognosis and usually needs ICD
implantation. Whether successful RF ablation of VT in this setting could avoid
the need of ICD implantation is unknown.
Methods: 158 successive pts with SHD (133 men, age 64±10) were fol-
lowed after RF ablation of MSVT. An ICD was not implanted because of end
stage pathology (6%), advanced age (17%), well-tolerated MSVT (61%) or
preserved EF (65%). 63 pts were on amiodarone and 90 on beta-blockers.
Results: 179 procedures were performed at 7 centers. Coronary artery disease
was present in 86 pts, right ventricular dysplasia in 16 pts, dilated cardiomyopathy
in 34 pts and various SHD in the remaining. Mean EF was 48±12% (30% with
EF < 0,40). VT rate was 169±33 bpm with syncope or near-syncope in 28%. 15%
presented with electrical storm. Ablation was performed using various techniques
and end points. Complete acute success was considered achieved in 87% and
undetermined in 5 pts. Complications occurred in 17 pts (arterial dissection/occlu-
sion, tamponnade or pericardial effusion, AV block and hematomas or femoral
aneurisms). Patients were discharged on beta-blockers (99 pts) and amiodarone
(42 pts). Mean follow-up was 27±20 months. VT recurred in 16% (10±11 months)
without compromise of the vital status. Mortality rate was 17% (2 late SD)
(22±20 months). Additional RF ablations were performed again in 15 pts with
recurring VT and VT further recurred in 4 while SD occurred in 2. An ICD was
finally implanted in 7 pts. There was no difference in VT recurrence rate
according to mortality, to the cardiopathy, clinical variables, EF, VT rate and tol-
erance or to residual VT inducibility. Mortality was related to syncope, VT rate,
EF, age, residual VT inducibility, electrical storm or number of targetted VT.
Conclusions: RF ablation for VT occurring in pts with SHD without ICD
appears safe and efficient and might be now proposed as an alternative for
ICD implantation because of associated morbidity, advanced age or when VT
is well tolerated and does not occur in the context of advanced heart disease.
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Background: Despite isolated reports of Brugada pattern in inferior or lat-
eral leads, prevalence and prognostic value of ST elevation in peripheral limb
ECG leads in patients with Brugada syndrome (BS) remains poorly known.
Methods: ECGs from 238 BS patients with spontaneous or drug induced
type 1 ECG (45±12 years old, 188 males) were reviewed. Baseline ECG
(n=126) or ECG after provocative test (n=112) with the highest ST elevation
were selected in each patient. 99 patients were implanted with an ICD.
72 patients (30%) presented an arrhythmic event defined by unexplained syn-
cope (54 pts), SD (8 pts) or ICD appropriated therapies (14 pts).











Tpe V1 (ms) 62±17 75±17 88±29 <0.001
Tpe V2 (ms) 66±20 85±23 84±19 <0.001
Tpe V3 (ms) 70±18 84±25 89±20 <0.001
Tpe V4 (ms) 69±18 79±20 90±26 <0.001
Tpe V5 (ms) 68±17 72±16 72±20 0,117
Tpe V6 (ms) 66±17 71±16 72±17 0,055
Tpe max (ms) 78±15 101±19 110±24 <0,001
Tpe dispersion 
(ms)
30±11 44±20 47±26 <0,001
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Results: 21 pts (9%) presented with type 1 in at least 1 peripheral leads:
16 pts (7%) in aVR lead, 5 pts in inferior leads and none in lateral leads. Type
1 in limb leads was associated with a type 1 in right precordial leads in each
pt, and was spontaneous in 8 pts (38%) and induced by drug challenge in
13 pts (62%). 15 of them have results of genetic testing (7 had SCN5A mutation).
There was a trend toward longer PR interval in patients with type 1 ECG
in limb leads (192±39 ms vs 176±35ms, p=0.09).
These patients present more frequently with arrhythmic events (57% vs
33%, p=0.009), with syncope (48% vs. 26%, p=0.0002), ICD appropriated
therapies (24% vs. 6%, p<0.001) and a trend toward more frequent SD (10%
vs 4%, p=0.1).
In multivariate analysis, type 1 ECG in limb leads was independently asso-
ciated with arrhythmic events (OR 3.08, [1.17-8.1], p=0.022) or with SD or
appropriate ICD therapy (OR 4.5 [1.32-15.3], p=0.016).
Conclusion: Type 1 Brugada pattern in peripheral limb ECG leads can be
seen in around 10% in patients with BS, mostly in aVR lead but also in infe-
rior leads. Type 1 ST elevation in limb leads is an independent predictive
factor of arrhythmic event in BS patients. This simple ECG parameter could
be used for further risk stratification.
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Nathalie Behar [Orateur] (1), Gaëlle Kervio (2), Bertrand Petit (3), Pierre
Maison-Blanche (4), François Carré (5), Philippe Mabo (1)
(1) CHU Pontchaillou, Cardiologie, Rennes Cedex 09, France – (2) CIC-
IT, Rennes, France – (3) CHU Réunion, Cardiologie, Saint Pierre, France
– (4) Hôpital Lariboisière, Paris, France – (5) CHU Pontchaillou, Explo-
rations Fonctionnelles, Rennes, France
Introduction: Risk stratification in Brugada syndrome (BS) remains a key
issue. Cardiac autonomic dysfunction has been proposed as a precipitating
factor of arrhythmic events in BS. The aim of the present study was to assess
cardiac response to autonomic innervation using heart rate variability (HRV),
in symptomatic patients with a BS compared to asymptomatic patients.
Methods: Twenty-two patients with BS were studied. Group S (mean
age=45.5±11 years, men: n=9) consisted of 10 symptomatic patients (3 cardiac
arrest, 4 syncope, 1 nocturnal convulsions and 2 lipothymia) and group A
(mean age=39.9±13.9 years, men: n=5) of 12 asymptomatic patients. HRV
was obtained, using dedicated software, on 24 hours Holter recording. We
studied time and frequency domains during a day-period (16h-20h) and a
night-period (0h-4h), using mean values and variation coefficients for each
period.
Results: In time and frequency domain, no difference was found between
the 2 groups, during the whole recording, night or day period. During night
period, patients from group S have higher variations than patients from group
A for HFn.u. (45.9±10.5 vs 34.6±13%, p<0.05) and LF/HF (56.7±10.7 vs
44.2±18, p<0.05). No difference was found during day. This higher variation
of frequency domain parameters during night in symptomatic patients relates
a more variable sinusal node response to the cardiac autonomic innervation.
Conclusion: Symptomatic patients with BS have higher variations of car-
diac response to the autonomic innervation during night resulting from either
higher sinus node sensitivity to autonomic influx or higher variation of these
influxes. The occurrence of symptoms in BS will be underlined by sponta-
neous higher variations of cardiac response to autonomic nervous system
especially during night.
215
Avoiding shocks by programming antitachycardia pacing for fast ventri-
cular tachycardia: how many attempts are needed? A prospective study
Raphaël Martins [Orateur] (1), Hugues Blangy (2), Lucian Muresan (2),
Luc Freysz (2), Laurent Groben (2), Pierre-Yves Zinzius (2), Jérôme
Schwartz (2), Jean-Marc Sellal (2), Etienne Aliot (2), Nicolas Sadoul (2)
(1) CHU Rennes, Cardiologie, Rennes, France – (2) CHU Nancy, Nancy,
France
Introduction: Antitachycardia pacing (ATP) is a painless therapy reducing
shocks in implantable cardioverter-defibrillator (ICD) recipients. One or 2 ATP
attempts are usually programmed to terminate fast ventricular tachycardia (FVT)
episodes without delaying successful shock if ATP fails. Programming more ATP
attempts could probably reduce the occurrence of shocks.
Objective: We sought to analyze the long-term efficacy and safety of pro-
gramming a high number of ATP attempts for FVT.
Methods: Patients receiving a first ICD for coronary artery disease and
dilated cardiomyopathy in primary and secondary prevention indications
between 2000 and 2009 were prospectively included. ICDs were programmed
to deliver 10 ATP attempts for FVT cycle lengths (CL) of 250 to 300 ms (200
to 240 bpm) before shock delivery (5 bursts then 5 ramps; 10 pulses at 81 to
88% of the FVT CL; minimal pacing CL 180 ms).
Results: 770 patients were prospectively included and followed for
40±25 months. Among them, 137 patients (17.8%) had a total of 1839 epi-
sodes of FVT (rate 209±9 bpm). ATP terminated 1713 episodes of FVT (effi-
cacy, 93.1%) and accelerated 5.8% of episodes. A majority of episodes were
successfully treated (98.3%) by 1 or 2 ATP attempts. Conversely, the patient-
based analysis showed that 17 (12.4%), 8 (5.8%) and 5 patients (2.1%) had
one episode or more treated by at least 3, 4 or 5 ATP attempts, respectively.
These patients would have been shocked with a conventional ICD program-
ming. The benefit of this strategy was reduced for 6 to 10 attempts and only
10 patients were shocks for ATP failure (20 episodes, 1.1%). Despite the high
number of attempts programmed, FVT episodes were mainly asymptomatic
and found during device interrogation: syncope and pre-syncope occurred in
0.2% and 0.4% of episodes, respectively.
Conclusion: Programming a high number of ATP attempts (at least 4 or 5
ATP attempts) for FVT is both safe and useful. It could prevent painful shocks
in a high proportion of ICD recipients.
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Introduction: the assessment of the arrhythmia risk is an important issue
after myocardial infarction (MI). The role of autonomic nervous system in
arrhythmia stratification risk is well validated. Holter parameters can reflect
both components of the autonomic nervous system: the sympathic and the
parasympathic. There is little data concerning the relation between risk strati-
fication parameters and the MI localization.
Aim: Comparison of Holter parameters exploring the autonomic nervous
system in patients having anterior and inferior myocardial infarction.
Methods: This prospective study included 90 patients (mean age 58±10 years)
hospitalized for recent myocardial infarction who underwent 24 hour Holter
monitoring. We analysed the number of premature beats(PB), heart rate vari-
ability (HRV) parameters (SDNN, RMSSD), QT intervals and heart rate tur-
bulence (TO et TS)
Results: 50 patients had anterior MI and 40 patients had inferior MI. There
was no significant difference between both groups regarding HRV and heart
rate turbulence. Where as in patients having anterior MI the QT interval was







Number PB/ 24H 46±8 52±8 NS
SDNN 92±39 104±34 NS
RMSSD 40±20 36±21 NS
QT apex 349±27 340±22 NS
QT end 431±33 416±24 0.03
TO – 0.011 – 0.007 NS
TS 8.41 9.37 NS
